Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1987 1
1992 1
1993 1
1994 4
2004 1
2009 1
2011 1
2013 2
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Use of cyclosporine in renal transplantation.
Lloveras J. Lloveras J. Transplant Proc. 2004 Mar;36(2 Suppl):107S-113S. doi: 10.1016/j.transproceed.2004.01.064. Transplant Proc. 2004. PMID: 15041317 Review.
Between 1982 and 1985 several large multicenter trials and the reports from large series of patients evidenced that cyclosporine was a major advance in the prevention of acute rejection episodes and in improving short-term and long-term graft survival. Cyclosporine …
Between 1982 and 1985 several large multicenter trials and the reports from large series of patients evidenced that cyclosporine was a major …
Estimation of renal allograft half-life: fact or fiction?
Seron D, Moreso F, Arias M, Campistol JM, Curto J, Hernandez D, Morales JM, Sanchez-Fructuoso A, Abraira V; Spanish Late Allograft Dysfunction Study Group. Seron D, et al. Nephrol Dial Transplant. 2011 Sep;26(9):3013-8. doi: 10.1093/ndt/gfq788. Epub 2011 Feb 3. Nephrol Dial Transplant. 2011. PMID: 21292814
INTRODUCTION: Renal allograft half-life time (t) is the most straightforward representation of long-term graft survival. Since some statistical models overestimate this parameter, we compare different approaches to evaluate t. ...
INTRODUCTION: Renal allograft half-life time (t) is the most straightforward representation of long-term graft survival. Since some s …
Long-term function of islet autotransplants.
Farney AC, Najarian JS, Nakhleh R, Field MJ, Morel P, Lloveras J, Gores PF, Sutherland DE. Farney AC, et al. Among authors: lloveras j. Transplant Proc. 1992 Jun;24(3):969-71. Transplant Proc. 1992. PMID: 1604690 No abstract available.
Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey.
Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A, Burghoffer B, Noel D, Barbut F; ICD-Raisin Working Group. Eckert C, et al. Med Mal Infect. 2013 Feb;43(2):67-74. doi: 10.1016/j.medmal.2013.01.004. Epub 2013 Mar 14. Med Mal Infect. 2013. PMID: 23498135
RESULTS: One hundred and five HCF with acute care wards and 95 with rehabilitation/long-term care (RLTC) wards participated in the 6-month epidemiological study. ...
RESULTS: One hundred and five HCF with acute care wards and 95 with rehabilitation/long-term care (RLTC) wards participated in the 6- …
De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
Crespo M, Mir M, Marin M, Hurtado S, Estadella C, Gurí X, Rap O, Moral R, Puig JM, Lloveras J. Crespo M, et al. Among authors: lloveras j. Transplant Proc. 2009 Jul-Aug;41(6):2115-7. doi: 10.1016/j.transproceed.2009.05.014. Transplant Proc. 2009. PMID: 19715848
CONCLUSIONS: Among de novo renal cases, the new once-daily formulation of tacrolimus offered a similar short-term efficacy profile as the twice-daily tacrolimus. But it was necessary to use up to a 50% higher dose of Advagraf than Prograf to achieve similar trough levels d …
CONCLUSIONS: Among de novo renal cases, the new once-daily formulation of tacrolimus offered a similar short-term efficacy profile as …
The efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open-label comparative study.
Mühlbacher F, Neumayer HH, del Castillo D, Stefoni S, Zygmunt AJ, Budde K; European Rapamune Cyclosporine Minimization Study Group. Mühlbacher F, et al. Transpl Int. 2014 Feb;27(2):176-86. doi: 10.1111/tri.12228. Epub 2013 Nov 25. Transpl Int. 2014. PMID: 24266855 Free article. Clinical Trial.
Sirolimus administered with rCsA and corticosteroids provided adequate immunosuppression while reducing the potential for the nephrotoxic effects of cyclosporine. These findings may help to improve long-term renal allograft outcomes....
Sirolimus administered with rCsA and corticosteroids provided adequate immunosuppression while reducing the potential for the nephrotoxic ef …
Letter: Long-term peritoneal dialysis.
Brulles A, Caralps A, Andreu J, Masramón J, Lloveras J, Gil-Vernet JM. Brulles A, et al. Among authors: lloveras j. Lancet. 1974 Apr 6;1(7858):624-5. doi: 10.1016/s0140-6736(74)92680-4. Lancet. 1974. PMID: 4132284 No abstract available.
Free intraperitoneal islet autografts in pancreatectomized dogs--impact of islet purity and posttransplantation exogenous insulin.
Wahoff DC, Sutherland DE, Hower CD, Lloveras JK, Gores PF. Wahoff DC, et al. Among authors: lloveras jk. Surgery. 1994 Oct;116(4):742-8; discussion 748-50. Surgery. 1994. PMID: 7940174

Intravenous glucose tolerance tests were done at 60 and 180 days. RESULTS: The long-term graft functional survival rate of intraperitoneal DPIT graft was significantly better than the rate of intraperitoneal purified islets (p < 0.01) and was as good as the rate of intr

Intravenous glucose tolerance tests were done at 60 and 180 days. RESULTS: The long-term graft functional survival rate of intraperit …
13 results